<!DOCTYPE html>
<html>
<head>
	<meta charset="UTF-8">
	<script type="text/javascript">
	var methode = {};
	window.globe = window.globe || {};
	globe.version = '18279I1728';
</script>
<!-- /business auto:  -->
	<title>Cambridge biotech Agios wins approval for its leukemia drug - The Boston Globe</title>
<meta name="eomportal-instanceid" content="218"/>
<meta name="eomportal-id" content="1460100"/>
<meta name="eomportal-loid" content="4.3.3688958225"/>
<meta name="eomportal-uuid" content="337857c8-76d9-11e7-b768-a68a15ffb042"/>
<meta name="eomportal-lastUpdate" content="Tue Oct 10 02:13:26 EDT 2017"/>
<title>Cambridge biotech Agios wins approval for its leukemia drug - The Boston Globe</title>
<!-- Methode uuid: "337857c8-76d9-11e7-b768-a68a15ffb042" -->
<script src="//cdn.blueconic.net/bostonglobemedia.js"></script>

	<meta property="og:type" content="article"/>
	<meta property="og:description" content="It’s the first treatment for a form of cancer that kills more than 10,500 people every year.   "/>
	<meta property="og:title" content="Cambridge biotech Agios wins approval for its leukemia drug - The Boston Globe"/>
	<meta property="og:site_name" content="BostonGlobe.com" />
	<meta property="fb:admins" content="100001044693856" />
	<meta property="fb:admins" content="507486035" />
	<meta property="fb:app_id" content="103933749691726" />
	<meta property="fb:pages" content="5637143257" />
	<meta property="article:publisher" content="https://www.facebook.com/globe" />
	<link rel='apple-touch-icon' sizes='57x57' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-57x57.png'>
	<link rel='apple-touch-icon' sizes='60x60' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-60x60.png'>
	<link rel='apple-touch-icon' sizes='72x72' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-72x72.png'>
	<link rel='apple-touch-icon' sizes='76x76' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-76x76.png'>
	<link rel='apple-touch-icon' sizes='114x114' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-114x114.png'>
	<link rel='apple-touch-icon' sizes='120x120' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-120x120.png'>
	<link rel='apple-touch-icon' sizes='144x144' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-144x144.png'>
	<link rel='apple-touch-icon' sizes='152x152' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-152x152.png'>
	<link rel='apple-touch-icon' sizes='180x180' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-180x180.png'>

	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-16x16.png' sizes='16x16'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-32x32.png' sizes='32x32'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-96x96.png' sizes='96x96'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-194x194.png' sizes='194x194'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-192x192.png' sizes='192x192'>

	<link rel='mask-icon' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/safari-pinned-tab.svg' color='#000000'>

	<link rel="shortcut icon" type="image/gif" href="/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/favicon.ico" />

	<meta name='msapplication-TileColor' content='#ffffff'>
	<meta name='msapplication-TileImage' content='//c.o0bg.com/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/mstile-144x144.png'>
	<meta name='theme-color' content='#ffffff'>

	<!--[if gte IE 9 ]>
	<meta name="application-name" content="Homepage"/>
	<meta name="msapplication-tooltip" content="This is the tooltip"/>
	<meta name="msapplication-starturl" content="/?comp=9"/>
	<![endif]-->

	<!--[if lte IE 8 ]>
	<meta name="application-name" content="Boston Globe"/>
	<meta name="msapplication-TileColor" content="#000000"/>
	<meta name="msapplication-TileImage" content="25a75e8d-4542-40a4-80aa-253aea7efc28.png"/>
	<link rel="stylesheet" media="print" href="/css/globe-ie-print.css?v=18279I1728" type="text/css" />
	<![endif]-->

	<meta property="twitter:account_id" content="95431448" />
<meta name="robots" content="noarchive" />
<meta name="description" content="It’s the first treatment for a form of cancer that kills more than 10,500 people every year.   " />
<meta name="keywords" content="agios,celgene,idhifa,fda,leukemia, Katherine Taylor, Richard  Pazdur,Boston Globe, Food and Drug Administration, Celgene Corporation, National Cancer Institute, National Institutes of Health, American Cancer Society, Abbott Laboratories,Celgene Corporation|CELG|NASDAQ, Abbott Laboratories|ABT|NYSE" />
<meta name="news_keywords" content="agios,celgene,idhifa,fda,leukemia, Katherine Taylor, Richard  Pazdur,Boston Globe, Food and Drug Administration, Celgene Corporation" />
<meta property="og:url" content="https://www.bostonglobe.com/business/2017/08/01/cambridge-biotech-agios-wins-approval-for-its-leukemia-drug/tMwJKxcdKdita5vl3C90XN/story.html"/>
<link rel="canonical" href="https://www.bostonglobe.com/business/2017/08/01/cambridge-biotech-agios-wins-approval-for-its-leukemia-drug/tMwJKxcdKdita5vl3C90XN/story.html" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:site" content="BostonGlobe" />
<link rel="amphtml" href="https://www.bostonglobe.com/business/2017/08/01/cambridge-biotech-agios-wins-approval-for-its-leukemia-drug/tMwJKxcdKdita5vl3C90XN/amp.html" />
	<meta property="og:image" content="http://www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2016/05/20/BostonGlobe.com/Business/Images/Taylor,24agios,business_06A.jpg" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />
<meta name="viewport" content="width=device-width, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no" /> <!--[if gte IE 6]><link href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-print.css" rel="stylesheet"><![endif]-->
<!--[if !IE]><link href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-print.css?v=18279I1728" rel="stylesheet" media="only all"><![endif]-->
<!-- /business and story -->
<script src="/js/lib/jquery.js,dist/globe.js,dist/bglobesubs.js,dist/inline-newsletter.js,dist/brightcove-asset-loader.js,dist/globe-article.js?v=18279I1728"></script>
<link rel="stylesheet" type="text/css" media="all" href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-topic-nav.css,globe-comments.css?v=18279I1728"/>
<!-- oas_sitepage:/business/homepage -->
<!-- webtype is story section is  adPageType article oas_sitepage /business/homepage-->

<!-- taxonomy: Business/Biotechnology rank: 105000 lowestRank: 105000 section: /business -->
		<!--  lowestRank: 105000 taxonomy: Business/Biotechnology section: /business -->

		<!-- admode:  smode user -->
		<script type="text/javascript">
      var googletag = googletag || {};
      googletag.cmd = googletag.cmd || [];

      function oxDone() {
        var gads = document.createElement("script");
        gads.async = true;
        gads.type = "text/javascript";
        gads.src = "//www.googletagservices.com/tag/js/gpt.js";
        var node = document.getElementsByTagName("script")[0];
        node.parentNode.insertBefore(gads, node);
      }

      
      var OX_dfp_ads = [];

    </script>

    <!-- modAdunit: bostonglobe.com/business  -->
    <script>
    	  var globe = globe || {};
	      globe.dfp = {
	        networkCode: 61381659
	      };

          globe.dfp.keyValuePairs = {
            s1: 'bostonglobe.com',
            s2: 'business',
            s3: '',
            s4: '',
            pgtype: 'article',
            pageurl: '_business_2017_08_01_cambridge-biotech-agios-wins-approval-for-its-leukemia-drug_tMwJKxcdKdita5vl3C90XN_story_html',
            meta: "agios,celgene,idhifa,fda,leukemia",
            weather: "",
            temp: "",
            aam: ""
        }
        globe.dfp.adUnit = 'bostonglobe.com/business';
    </script>
<!-- Facebook Pixel Code -->
<script>
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()
{n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
;if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
document,'script','https://connect.facebook.net/en_US/fbevents.js');
fbq('init', '884869448226452');
fbq('track', "PageView");</script>
<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=884869448226452&ev=PageView&noscript=1"
/></noscript>
<!-- End Facebook Pixel Code -->
</head>

<body itemscope itemtype="http://schema.org/WebPage" class='type-internal type-article section-business & tech business & tech type-business & tech logged-out'>

<div id="contain">
<!-- type:EOM::CompoundStory autosection: section class:Business & Tech section:/business-->
<!-- topSection2 /business -->

<header class="bg-header clearfix">
	<div class="bg-header__subinfo bg-header__subinfo--tablet">
		<div class="js-user-subscribe" data-baseurl="https://www.bostonglobe.com"></div>
			</div>
	    <div id="smartbar" class="bg-header__smartbar bg-header__smartbar--longtitle" data-hide-on-load="true">
	       <a href="" class="bg-header__smartbar--message" onClick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar15,channel,prop1';s.linkTrackEvents='none';s.tl(this,'o','BG Header - Smart Bar_Marketing Gen');" data-logged-in-message='<span class="bg-header__smartbar--text-bold">Season Ticket</span> <span class="bg-header__smartbar--text">Listen now to the new sports podcast</span>' data-logged-in-link='https://bostonglobe.com/seasonticket' data-logged-out-message='<span class="bg-header__smartbar--text-bold">SUBSCRIBE NOW</span> <span class="bg-header__smartbar--text">Get unlimited access to Globe.com today</span>' data-logged-out-link='http://subscribe.bostonglobe.com/B6455/?p1=BGHeader_SmartBar_Marketing_Sub'>
	</a>
</div>
	<div class="bg-header__menus">
		<a href="#" class="bg-header__button bg-header__hamburger js-open-menu" onclick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','BG Menu - Open');">Menu</a>
		<a href="/?p1=BGHeader_Logo" class="bg-header__button bg-header__home"></a>
	</div>

	<div class="bg-header__subinfo">
	<div class="js-user-settings" data-location="" data-baseurl="https://www.bostonglobe.com"></div>
			<div class="js-user-subscribe" data-location="" data-baseurl="https://www.bostonglobe.com"></div>
		</div>

<a href="/business?p1=BGHeader_SectionLink" class="bg-header__centerpiece bg-header__logo-wrapper bg-header__centerpiece--longtitle">
               <div class="bg-header__logo"></div>
			<div class="bg-header__section-front">Business & Tech</div>

			</a>
		<nav class="bg-header__takeover" aria-hidden="true">
				<div class="bg-header__takeover-full-screen">
					<div class="bg-header__menu-wrapper">
	   					<div class="bg-header__close js-close-menu">
		   				</div>
		   				<a href="" class="bg-header__home"></a>

			   			<!-- Logged out Subinfo -->
						<div class="bg-header__subinfo">
	<div class="js-user-settings" data-location="menu" data-baseurl="https://www.bostonglobe.com"></div>
			<div class="js-user-subscribe" data-location="menu" data-baseurl="https://www.bostonglobe.com"></div>
		</div>

<a href="/?p1=BGMenu_Logo" class="bg-header__logo"></a>

						<div class="bg-header__menu">
							<section class="bg-header__menu-left">
								<ul class="bg-header__sections">
									<li class="bg-header__section">
													<a href="/metro?p1=BGMenu" class="bg-header__link">Metro</a>
												</li>
											<li class="bg-header__section">
													<a href="/sports?p1=BGMenu" class="bg-header__link">Sports</a>
												</li>
											<li class="bg-header__section">
													<a href="/business?p1=BGMenu" class="bg-header__link">Business & Tech</a>
												</li>
											<li class="bg-header__section">
													<a href="/opinion?p1=BGMenu" class="bg-header__link">Opinion</a>
												</li>
											<li class="bg-header__section">
													<a href="/news/politics?p1=BGMenu" class="bg-header__link">Politics</a>
												</li>
											<li class="bg-header__section">
													<a href="/lifestyle?p1=BGMenu" class="bg-header__link">Lifestyle</a>
												</li>
											<li class="bg-header__section">
													<a href="/arts?p1=BGMenu" class="bg-header__link">Arts</a>
												</li>
											<li class="bg-header__section">
													<a href="http://www.boston.com/section/cars" class="bg-header__link"
														target="_blank"
														onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Menu - Nav - Cars');">
														Cars</a>
												</li>
											<li class="bg-header__section">
													<a href="http://realestate.boston.com" class="bg-header__link"
														target="_blank"
														onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Menu - Nav - Real Estate');">
														Real Estate</a>
												</li>
											</ul>
							</section>
							<section class="bg-header__menu-right">
								<div class="bg-header__recommended">
									<p class="bg-header__recommended-header">
										Most popular on BostonGlobe.com
									</p>
									<p class="bg-header__recommended-subhead">Based on what you&#39;ve read recently, you might be interested in theses stories</p>
								</div>
								<div class="bg-header__suggestions">
		<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/sports/redsox/2017/10/09/shaughnessy/EK3NwkqZneeTdMOnc8qr0N/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/09/BostonGlobe.com/ReceivedContent/Images/Grossfeld4ALDS2.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Dan Shaughnessy: Red Sox stars did not deliver when it mattered most</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/lifestyle/names/2017/10/09/report-matt-damon-helped-kill-earlier-new-york-times-story-about-harvey-weinstein/2TDJnvLT0eDq9HhuvdmXjP/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/09/19/BostonGlobe.com/Lifestyle/Images/06196800.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Report: Matt Damon helped kill earlier New York Times story about Harvey Weinstein</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/metro/2017/10/04/rex-tillerson-secretary-bleeping-state-chaos/TyU9L2FmqJBkpJcNcui5VJ/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/04/BostonGlobe.com/Metro/Images/Rex_US_Secretary_of_State_Rex_Tiller_9114668V.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Rex Tillerson, secretary of a (bleeping) state of chaos</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/business/2017/10/09/homeowner-deck-nightmare/C7IN6Ej7pNmNASrIz7ormI/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/09/BostonGlobe.com/Business/Images/consumerwiggs_Home_02.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Homeowner’s deck nightmare</figcaption>
	 					</a>
		   			</figure>
				</div>
<form action="/queryResult/search" class="bg-header__search" method="get" role="search">
						        <div class="search-inputs">
									<input type="text" class="bg-header__input" id="q" placeholder="Search BostonGlobe.com" role="search" name="q">
								</div>
							</form>
							</section>
							<ul class="bg-header__more-sections">
								<li class="bg-header__section">
										<a href="/todayspaper?p1=BGMenu_Subnav" class="bg-header__link">Today's Paper</a>
									</li>
								<li class="bg-header__section">
										<a href="/magazine?p1=BGMenu_Subnav" class="bg-header__link">Magazine</a>
									</li>
								<li class="bg-header__section">
										<a href="/metro/obituaries?p1=BGMenu_Subnav" class="bg-header__link">Obituaries</a>
									</li>
								<li class="bg-header__section">
										<a href="http://www.boston.com/weather?p1=BGMenu_Subnav" class="bg-header__link">Weather</a>
									</li>
								<li class="bg-header__section">
										<a href="/lifestyle/comics?p1=BGMenu_Subnav" class="bg-header__link">Comics</a>
									</li>
								<li class="bg-header__section">
										<a href="/lifestyle/crossword?p1=BGMenu_Subnav" class="bg-header__link">Crossword</a>
									</li>
								<li class="bg-header__section">
										<a href="/news/bigpicture?p1=BGMenu_Subnav" class="bg-header__link">The Big Picture</a>
									</li>
								</ul>
						</div>
						<aside class="bg-header__pop-up" aria-hidden="true">
					   		<div class="bg-header__close-pop-up js-close-pop-up"></div>
					   		<div class="bg-header__caret-wrapper"><div class="bg-header__caret"></div></div>
					   		<section class="bg-header__pop-up-section bg-header__pop-up-section--digital">
						   		<img src="/img/masthead/lockup.png" class="bg-header__sub-img"/>
					   			<p class="bg-header__sub-title">Digital Access</p>
					   			<p class="bg-header__promo-text">99 cents a week for the first 4 weeks</p>
								<a href="https://subscribe.bostonglobe.com/B3853/?eglobe_rc=WW20167D&p1=BGMenu_DigitalSubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe Digital');">Subscribe</a>
								<a href="https://subscribe.bostonglobe.com/B3853/?rc=WW20167D&eglobe_rc=WW20167D&p1=BGMenu_DigitalSubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe Digital');">Subscribe</a>				   			</section>
					   		<section class="bg-header__pop-up-section bg-header__pop-up-section--delivery">
					   			<img src="/img/masthead/newspaper.png" class="bg-header__sub-img"/>
					   			<p class="bg-header__sub-title">Home Delivery</p>
					   			<p class="bg-header__promo-text">Save 50% off the regular rate</p>
								<a href="//homedelivery.bostonglobe.com/hd/26/order/zip/?rc=WW011964&globe_rc=WW011964&p1=BGMenu_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe HD');">Subscribe</a>
		   						<a href="https://subscribe.bostonglobe.com/B8554/?rc=WW011964&globe_rc=WW011964&p1=BGMenu_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe HD');">Subscribe</a>
					   		</section>
				   			<span class="bg-header__sub-login">Already a subscriber? <a href="https://www.bostonglobe.com/login?p1=BGMenu_Login_Link" class="bg-header__sub-click" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar27,events';s.linkTrackEvents='event15';s.eVar27='BG Menu Modal';s.events='event15';s.tl(this,'o','BG Menu Modal - Log In');">Members Sign In</a></span>
				   		</aside>
	   				</div>
	   			</div>
   			</nav>



   	<aside class="bg-header__pop-up" aria-hidden="true">
   		<div class="bg-header__close-pop-up js-close-pop-up"></div>
   		<div class="bg-header__caret-wrapper"><div class="bg-header__caret"></div></div>
   		<section class="bg-header__pop-up-section bg-header__pop-up-section--digital">
   			<img src="/img/masthead/lockup.png" class="bg-header__sub-img"/>
   			<p class="bg-header__sub-title">Digital Access</p>
   			<p class="bg-header__promo-text">99 cents a week for the first 4 weeks</p>
		    <a href="https://subscribe.bostonglobe.com/B3605/?eglobe_rc=WW20145D&p1=BGHeader_DigitalSubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	Digital');">Subscribe</a>
			<a href="https://subscribe.bostonglobe.com/B3605/?rc=WW20145D&eglobe_rc=WW20145D&p1=BGHeader_DigitalSubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	Digital');">Subscribe</a>

   		</section>
   		<section class="bg-header__pop-up-section bg-header__pop-up-section--delivery">
   			<img src="/img/masthead/newspaper.png" class="bg-header__sub-img"/>
   			<p class="bg-header__sub-title">Home Delivery</p>
   			<p class="bg-header__promo-text">Save 50% off the regular rate</p>
			<a href="//homedelivery.bostonglobe.com/hd/26/order/zip/?rc=WW011964&globe_rc=WW011964&p1=BGHeader_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	HD');">Subscribe</a>
			<a href="https://subscribe.bostonglobe.com/B0004/?rc=WW011964&globe_rc=WW011964&p1=BGHeader_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	HD');">Subscribe</a>
   		</section>
   		<span class="bg-header__sub-login">Already a subscriber? <a href="https://www.bostonglobe.com/login?p1=BGHeader_Login_Link" class="bg-header__sub-click" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar27,events';s.linkTrackEvents='event15';s.eVar27='BG Header Modal';s.events='event15';s.tl(this,'o','BG Header Modal - Log In');">Members Sign In</a></span>
   	</aside>

</header>
<!-- story_default.jpt, story id:b7c7e592-76d5-11e7-af4f-c28365d4658d path:/Boston/2011-2020/2017/08/01/BostonGlobe.com/Business/Stories -->

		<div class="ad billboard" id="ad_outofpage2"></div>  <div class="ad billboard" id="ad_billboard"></div>  <div class="mod live-update">
			</div>

		<main id="main" role="main" class="eptClick">
			<article class="article" itemscope="itemscope"
				itemtype="http://schema.org/NewsArticle">
				<meta itemprop="inLanguage" content="en-US" />
				<meta itemprop="genre" content="news" />
				<meta itemprop="articleSection" content="Business & Tech" />
				<!-- Headline Section -->
				<header>
	<div class="header new">
	<h1 class="main-hed" itemprop="headline">Cambridge biotech Agios wins OK for its leukemia drug</h1>
	</div>
	
	</header>
<div class="article-body">
					<!-- position:Top -->
<!--
METADATA FOR EMTAF
      <headline>Cambridge biotech Agios wins OK for its leukemia drug</headline>
      <source>Globe Staff</source>
      <teasetext>It&amp;rsquo;s the first treatment for a form of cancer that kills more than 10,500 people every year.  </teasetext>
      <byline>By Jonathan Saltzman</byline>
      <date>20170801162313</date>
-->

<aside class="tools">
	<ul class="Top tools primary-tools">
		<!-- imgAltCaption: May 20, 2016 - Agios Pharmaceuticals - Cambridge, MA Agios Pharmaceuticals CSO (chief drug hunter) Scott Biller (L) and CEO David Schenkein (R) stand for a portrait in their office building 24agios, business, weisman Photo by Katherine Taylor for The Boston Globe -->
		<li class="email">
	      <a class="bg-button--email email" onClick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Email_Top');" data-omniture="BG Article Share Tools - Email - Top" target="_blank" title="Share via E-mail" aria-label="Share via E-mail" href="#"><span class="bg-icon--email">E-Mail</span></a>
	      <div class="email-form">
				<h4>Share via e-mail</h4>
				<div class="email-error"></div>
				<form action="" method="post">
					<input type="hidden" id="story_url-Top" name="story_url" value="http://www.bostonglobe.com/business/2017/08/01/cambridge-biotech-agios-wins-approval-for-its-leukemia-drug/tMwJKxcdKdita5vl3C90XN/story.html"/>
					<p>
						<label for="email-to-primary-Top">To</label>
						<input type="text" name="email-to-primary" id="email-to-primary-Top" placeholder="Separate multiple addresses with a comma" />
					</p>
					<p>
						<label for="email-mssg-primary-Top">Add a message</label>
						<textarea name="email-mssg-primary" id="email-mssg-primary-Top" maxlength="80" placeholder="80 character limit"></textarea>
					</p>
					<p>
						<label for="email-from-primary-Top">Your e-mail</label>
						<input type="text" name="email-from-primary" id="email-from-primary-Top" />
					</p>
					<input type="submit" value="Send" class="bg-button" onClick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Send_Top');"/>
				</form>
			</div><!-- /end .email-form -->
	    </li>
	    <li>
	      <a class="bg-button--fb" data-omniture="BG Article Share Tools - Facebook - Top" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F08%2F01%2Fcambridge-biotech-agios-wins-approval-for-its-leukemia-drug%2FtMwJKxcdKdita5vl3C90XN%2Fstory.html%3Fevent%3Devent25&amp;t=Cambridge biotech Agios wins OK for its leukemia drug" target="_blank" title="Share on Facebook" aria-label="Share on Facebook"><span class="bg-icon--fb">Facebook</span></a>
	    </li>
	    <li>
	      <a class="bg-button--twitter" data-omniture="BG Article Share Tools - Twitter - Top" href="http://twitter.com/intent/tweet?text=Cambridge biotech Agios wins OK for its leukemia drug&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F08%2F01%2Fcambridge-biotech-agios-wins-approval-for-its-leukemia-drug%2FtMwJKxcdKdita5vl3C90XN%2Fstory.html%3Fevent%3Devent25&amp;via=BostonGlobe" target="_blank" title="Share on Twitter" aria-label="Share on Twitter"><span class="bg-icon--twitter">Twitter</span></a>
	    </li>
	    <li>
			<a class="bg-button--gplus" data-omniture="BG Article Share Tools - Google+ - Top" href="https://plus.google.com/share?url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F08%2F01%2Fcambridge-biotech-agios-wins-approval-for-its-leukemia-drug%2FtMwJKxcdKdita5vl3C90XN%2Fstory.html%3Fevent%3Devent25%26s_campaign%3dsm_gp%26hl=en-US" target="_blank" title="Share on Google+" aria-label="Share on Google+"><span class="bg-icon--gplus">Google+</span></a>
				</li>
	    <li>
	      <a class="bg-button--linkedin" data-omniture="BG Article Share Tools - Linkedin - Top" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F08%2F01%2Fcambridge-biotech-agios-wins-approval-for-its-leukemia-drug%2FtMwJKxcdKdita5vl3C90XN%2Fstory.html%3Fevent%3Devent25&amp;title=Cambridge biotech Agios wins OK for its leukemia drug&amp;summary=It%26amp%3Brsquo%3Bs+the+first+treatment+for+a+form+of+cancer+that+kills+more+than+10%2C500+people+every+year.++" target="_blank" title="Share on LinkedIn" aria-label="Share on LinkedIn"><span class="bg-icon--linkedin">LinkedIn</span></a>
	    </li>
	</ul>
	<a href="#comments" class="js-comments-toggle bg-button--generic">
		  <span class="bg-icon-comment-dark bg-icon--small"></span>
		  <span class="js-comment-count"></span> <span class="js-comment-count-label bg-visuallyhidden">Comments</span>
		</a>

	<a class="bg-button--generic bg-button--print" onclick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Print_Top')" href="javascript:print();">
			<span class="bg-icon--print bg-icon--small"></span>
			<span class="bg-visuallyhidden">Print</span></a>
		</aside>
<div class="sticky-tools">
		<a class="sticky-tools__button sticky-tools__button--home" href="/?p1=BGHeader_Logo_Sticky">
		    <span>The Boston Globe</span>
		</a><a class="sticky-tools__button sticky-tools__button--share tw" data-omniture="BG Article Share Tools - Twitter - Sticky" href="http://twitter.com/intent/tweet?text=Cambridge biotech Agios wins OK for its leukemia drug&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F08%2F01%2Fcambridge-biotech-agios-wins-approval-for-its-leukemia-drug%2FtMwJKxcdKdita5vl3C90XN%2Fstory.html%3Fevent%3Devent25%3Fevent%3Devent25&amp;via=BostonGlobe" target="_blank" title="Share on Twitter">
		    <span>Tweet</span>
		</a><a class="sticky-tools__button sticky-tools__button--share fb" data-omniture="BG Article Share Tools - Facebook - Sticky" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F08%2F01%2Fcambridge-biotech-agios-wins-approval-for-its-leukemia-drug%2FtMwJKxcdKdita5vl3C90XN%2Fstory.html%3Fevent%3Devent25%3Fevent%3Devent25&amp;tCambridge biotech Agios wins OK for its leukemia drug" target="_blank" title="Share on Facebook">
		    <span>Share</span>
		</a><a class="sticky-tools__button sticky-tools__button--share sticky-comments js-sticky-comments" href="#comments">
		    <span></span>
		    <p class="js-comment-count sticky-comments-count"></p>
		    <p class="js-comment-count-label sticky-comments-count-label"></p>
		</a>
		<div class="sticky-tools__button sticky-tools__button--top js-back-to-top"></div>
	</div>
<!-- Header Tabs Section -->
					<figure itemprop="associatedMedia" itemscope itemtype="http://schema.org/ImageObject" class="figure lead-figure full">
		<img  itemprop="contentUrl" src="//www.bostonglobe.com/rf/image_r/Boston/2011-2020/2016/05/20/BostonGlobe.com/Business/Images/Taylor,24agios,business_06A.r.jpg" data-fullsrc="//c.o0bg.com/rf/image_960w/Boston/2011-2020/2016/05/20/BostonGlobe.com/Business/Images/Taylor,24agios,business_06A.jpg" alt="May 20, 2016 - Agios Pharmaceuticals - Cambridge, MA Agios Pharmaceuticals CSO (chief drug hunter) Scott Biller (L) and CEO David Schenkein (R) stand for a portrait in their office building 24agios, business, weisman Photo by Katherine Taylor for The Boston Globe"/>
		<figcaption class="figcaption">
			<meta itemprop="creator" content="Katherine Taylor" />
			<p class="credit">Katherine Taylor/For The Boston Globe</p>
			<p itemprop="description caption">Agios Pharmaceuticals&#8217; chief scientific officer Scott Biller (left) and chief executive David Schenkein at the biotech&#8217;s Cambridge headquarters. </p>
		</figcaption>
	</figure>	
<div class="byline">
	<b class="author"><!---->By <a class="" title="More Stories by Jonathan Saltzman" href="/staff/saltzman" rel="author"><span itemprop="name">Jonathan Saltzman</span></a></b>
	Globe Staff&nbsp;
	<time itemprop="datePublished" datetime="2017-08-01 16:23">August 01, 2017</time>
	<p></p>
	<p></p>
</div><div class="article-text" itemprop="articleBody">
						<!-- leading video or graphic -->
						<!-- inside story_update.jpt -->
<!-- In Story Photo or Graphic Section -->
							<!-- paragraphs 16 leadingContainer photo
										leadingShape horizontal hasRBox false -->
									<!----><p>A drug hatched in the lab of a Massachusetts biotech won approval Tuesday from the Food and Drug Administration as a treatment for a devastating form of leukemia caused by a genetic mutation.</p><p>Idhifa is the first drug developed by Agios Pharmaceuticals Inc., a nine-year-old Cambridge start-up that has focused on medicines to stimulate the human body&rsquo;s immune response against cancer cells. Agios sold the rights to the medicine in 2010 to New Jersey-based Celgene Corp., which will market it and pay Agios royalties.</p><p class="skip-nav article-more">
	<a>Advertisement</a>
	</p>

<div class="ad aside" id="ad_bigbox1"></div>  <a id="skip-target1"></a>

<p>The medicine also is the first FDA-approved drug for acute myeloid leukemia (AML) in adult patients with a particular genetic mutation who suffer relapses despite other treatments. Those patients account for 9 to 13 percent of the more than 21,000 people diagnosed each year with the disease. </p><p>&ldquo;It&rsquo;s a very exciting day for patients,&rdquo; said Agios chief executive David Schenkein a hematologist and oncologist, after the FDA announced its approval. &ldquo;Acute myeloid leukemia essentially hasn&rsquo;t had a new treatment in the last 30 to 40 years.&rsquo;&rsquo;</p><div class="inline-newsletter" data-exact-target-ID="20712964" data-mailing-list-name="Talking Points" data-is-amp="" data-section="/business">
  <div class="inline-newsletter__network-error"></div>
  <div class="inline-newsletter__copy">
    <div class="inline-newsletter__title">
      Get <span class="inline-newsletter__bold">Talking Points</span> in your inbox:
    </div>
    <div class="inline-newsletter__description">
        An afternoon recap of the day’s most important business news, delivered weekdays.</div>
    </div>
  <form class="inline-newsletter__content" method="post">
    <div class="inline-newsletter__error-text"></div>
    <input placeholder="Enter email address" type="text" id="inline-newsletter-email-input" class="inline-newsletter__input">

    <div class="inline-newsletter__button-container">
      <button class="inline-newsletter__button">
        <span class="inline-newsletter__button-text">Sign Up</span>
      </button>
      <div class="inline-newsletter__spinner"></div>
    </div>
  </form>
  <div class="inline-newsletter__thanks">
    Thank you for signing up!
    <a href="/newsletters?p1=Article_inline-newsletterWidget_ThankYou_Link" class="inline-newsletter__link">Sign up for more newsletters here</a>
    </div>
</div>

<p>But like other breakthrough medicines, Idhifa won&rsquo;t come cheap: it&rsquo;s priced at nearly $300,000 a year.</p><!-- total:0 -->

<p>The rapidly-progressing form of cancer starts in the bone marrow but in most cases quickly moves into the blood. It sometimes spreads to other parts of the body, including the lymph nodes, liver, spleen, and central nervous system.</p><p>   More than 10,500 people will die from the disease this year, according to the National Cancer Institute at the National Institutes of Health. It generally afflicts older people and is uncommon before the age of 45, according to the American Cancer Society.  The five-year survival rate is less than 20 percent.</p><!--  working ad -->
<p class="skip-nav article-more">
	<a>Advertisement</a>
	<!-- <a href="#skip-target2">Continue reading below</a> -->
</p>
<!-- adLayerPath: /Boston/Production/BostonGlobe.com/WebPages/Homepage/homepage.ad-layer.story-asset.dwp -->
<div class="ad aside" id="ad_bigbox2"></div>  <a id="skip-target2"></a>

<p>For decades, intravenous chemotherapy has been the standard treatment even though it kills good and bad cells, Schenkein said. In contrast, Idhifa comes as a pill and is a targeted therapy that works by blocking several enzymes that promote cell growth.</p><p> In clinical trials, the drug &ldquo;was associated with a complete remission in some patients and a reduction in the need for both red cell and platelet transfusions,&rsquo;&rsquo; said Dr. Richard Pazdur, director of the FDA&rsquo;s Oncology Center of Excellence.</p><p> Idhifa is to be used along with a diagnostic test, developed by Illinois-based Abbott Laboratories, that is designed to detect the mutation.</p><p>Dr. Gwen Nichols, chief medical officer at the Leukemia &amp; Lymphoma Society, was pleased by the FDA&rsquo;s approval of Idhifa but noted that it&rsquo;s not a cure-all. &ldquo;I don&rsquo;t want people to think that this is the answer for all AML patients,&rdquo; she said. There are at least a dozen strains of acute myeloid leukemia, Nichols said, but she&rsquo;s hopeful that similar precision drugs will be developed to treat them. &ldquo;This is the tip of the iceberg,&rdquo; she said.</p><p>Indeed, Agios has a second drug in the pipeline to treat acute myeloid leukemia caused by another genetic mutation, according to company officials. The experimental treatment has undergone a set of clinical trials, and Agios hopes to apply for FDA approval by the end of this year. The company has retained worldwide rights to sell the medicine.</p><p>As for Idhifa, Schenkein said it took less than four years to develop, test, and clear government hurdles &mdash; an unusually swift process.</p><p>Agios has 350 employees and expects to add as many as 100 by the end of the year, according to a company spokeswoman.</p><p>The FDA had granted Idhifa &ldquo;priority review&rdquo; designation, enabling the agency to speed its drug approval process. The medicine had also received &ldquo;orphan drug&rdquo; designation, which gives companies incentives to develop treatments for rare diseases.</p><p>The drug&rsquo;s approval was expected, but Agios&rsquo;s share price still rose on Tuesday &mdash; up nearly 5 percent on the Nasdaq exchange, closing at $58.65.</p><!----><p></p><i>Jonathan Saltzman can be reached at <a class="a" href="mailto:jsaltzman@globe.com">jsaltzman@globe.com.</a></i><!-- inside story_update.jpt -->
</div><!-- end article-text -->
					<!-- Story tools -->
						<!-- for comments -->
					<footer class="article-footer" role="contentinfo">
<script>var uuid = 'b7c7e592-76d5-11e7-af4f-c28365d4658d';</script>
<div id="comments">
	<div id="comments-content" class="ugc-comments comments">
		<div class="loading-message" id="loading-comments">
			Loading comments...
			 </div>
	</div>
</div>
<div id="newcomments"></div>
</footer>
</div><!-- ends article-body -->
				<!-- place for ads and trending -->
				<nav id="section-nav" class="section-nav trending-nav" data-sectionname="/business">
     <h3>Top 10 Trending Articles</h3>
      <nav>
        <ul class="bg-tabs-sidebar bg-33-33-33">
          <li><a class="here js-show-tab" href="#most-viewed">Most Viewed</a></li>
          <li><a class="js-show-tab" href="#most-commented">Most Commented</a></li>
          <li><a class="js-show-tab" href="#most-shared">Most Shared</a></li>
        </ul>
      </nav>

      </nav>

  <div id="ad_outofpage1" class="ad outofpage1"></div>
</article>
		</main>
		<!-- Page footer -->
<div class="subscription-banner">
	<a class="subscription-banner__link" href="http://subscribe.bostonglobe.com/B0565?p1=BGFooter_DigitalSubscription_Banner">
		<span class="subscription-banner__title">Real journalists. Real journalism. </span>
		<span class="subscription-banner__cta" >Subscribe to The Boston Globe today.</span>
	</a>
</div>
<footer class="site-footer" role="contentinfo">
	<div class="site-footer__content">
		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">My Account</h3></li>
			<li class="site-footer__list-item"><a href="https://manage.bostonglobe.com/cs/mc/login.aspx?p1=BGFooter" class="site-footer__link">Manage my Account</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobe.com/bgcs" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - Download Customer Service App');">Mobile Customer Service</a></li>
			<li class="site-footer__list-item"><a href="/newsletters?p1=BGFooter_Newsletters" class="site-footer__link">Sign Up For Newsletters</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">Contact</h3></li>
			<li class="site-footer__list-item"><a href="https://bostonglobe.custhelp.com/app/home?p1=BGFooter" class="site-footer__link">Help</a></li>
			<li class="site-footer__list-item"><a href="https://bostonglobe.custhelp.com/app/answers/list?p1=BGFooter" class="site-footer__link">FAQs</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/stafflist?p1=BGFooter" class="site-footer__link">Globe newsroom</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobemedia.com/" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - BGM Home Page');">Advertise</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">Social</h3></li>
			<li class="site-footer__list-item"><a href="https://www.facebook.com/globe" class="site-footer__link">Facebook</a></li>
			<li class="site-footer__list-item"><a href="https://twitter.com/#!/BostonGlobe" class="site-footer__link">Twitter</a></li>
			<li class="site-footer__list-item"><a href="https://plus.google.com/108227564341535363126/about" class="site-footer__link">Google+</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">More</h3></li>
		    <li class="site-footer__list-item"><a href="http://epaper.bostonglobe.com/launch.aspx?pbid=2c60291d-c20c-4780-9829-b3d9a12687cf" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - EPaper launch');">ePaper</a></li>
			<li class="site-footer__list-item"><a href="http://nieonline.com/bostonglobe/" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - News In Education');">News in Education</a></li>
			<li class="site-footer__list-item"><a href="https://secure.pqarchiver.com/boston-sub/no_default.html?ss=1&amp;url=%2Fboston-sub%2Fadvancedsearch.html" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - Public Archives');">Archives</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/privacy?p1=BGFooter" class="site-footer__link">Privacy policy</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/terms-service?p1=BGFooter" class="site-footer__link">Terms of service</a></li>
			<li class="site-footer__list-item"><a href="/termsofpurchase?p1=BGFooter" class="site-footer__link">Terms of purchase</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobemedia.com/careers" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - BGM Careers');">Work at Boston Globe Media</a></li>
		</ul>
		<p class="site-footer__copyright">&copy; 2017 Boston Globe Media Partners, LLC</p>
	</div>
</footer>

<script type="text/javascript" src="//tags.mediaforge.com/js/4600"></script>

<script type="text/javascript">
	var google_conversion_id = 1071256246;
	var google_custom_params = window.google_tag_params;
	var google_remarketing_only = true;
</script>
<script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js" ></script>
<noscript>
	<div style="display:inline;">
		<img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/1071256246/?value=0&amp;guid=ON&amp;script=0"/>
	</div>
</noscript><div class="ad ad-slot-c" id="EXTRA"></div><!-- Tracking -->
<!-- stubView3 =  -->
<!-- sPageNameExt: Cambridge biotech Agios wins approval for its leukemia drug -->
		

		
			
			
				
			
		
		
		

		
		
			
				
			
		

		
			
		

	
	
	
	
	
	
	








	
		
	
	




<!-- sectionpath /business -->



<!-- pageTitle:  -->

<!-- Determine sprop_3 -->




	
		
	
	
		
		
		<!-- authors: Jonathan Saltzman -->
	

<script>
	var sPageName = (typeof sPageNameOverride != 'undefined') ? sPageNameOverride : 'Business | Cambridge biotech Agios wins approval for its leukemia drug';
	//if (typeof sPageNameOverride != 'undefined') {
	//	sPageName = sPageNameOverride;
	//}
	var sChannel = (typeof sChannelOverride != 'undefined') ? sChannelOverride : 'Business';
	//var sChannel  = 'Business';
	var sProp1    = 'Business';
	var sProp3    = 'Jonathan Saltzman';
	var sProp4    = 'Standard';
	//var sProp6    = 'Article Page | Globe Story';
	var sProp6    = (typeof sProp6Val != 'undefined') ? sProp6Val : 'Article Page | Globe Story';
	var sProp8	  = '08/01/2017 04:23:13 PM';
	var sProp16    = 'none';
	var sProp67	  = 'b7c7e592-76d5-11e7-af4f-c28365d4658d';
	var sProp68	  = 'Cambridge biotech Agios wins OK for its leukemia drug';
	var sProp6a = sProp6;
	var sProp1a = sProp1;
	var sPageNamea = sPageName;
	var taxonomies = 'Business/Biotechnology';
	var sChannela = sChannel;
	  if ( methode.showPaywall ) {
	    sChannel  = 'Member Center';
	    sProp1    = 'Member Center | BGC Registration';
	    if ( $(window).width() <= 768 ) {
	      // assume mobile
	      sPageName = 'Member Center | BGC Registration | Fullpage Paywall Challenge';
	      sProp6    = 'BGC Registration Page - Fullpage';
	    } else {
	      // assume desktop
	      sPageName = 'Member Center | BGC Registration | Modal Paywall Challenge';
	      sProp6    = 'BGC Registration Page - Modal';
	    }
	  }
	globe.extend(globe.analytics.omniture, {
	  'pageType' : '',
	  'pageName' : sPageName,
	  'channel'  : sChannel,
	  'prop1'    : sProp1,
	  'prop3'    : sProp3,
	  'prop4'    : sProp4,
	  'prop6'    : sProp6,
	  'prop8'    : sProp8,
	  'prop16'    : sProp16,
	  
		'prop35' : 'logged out',
		'eVar20' : 'logged out',
   		'prop42' : 'Metered',
   		'eVar42' : 'Metered',

	  'eVar16'   : 'none',
	  'eVar41'   : 'BostonGlobe.com',
	  'eVar41'   : 'BostonGlobe.com',
	  'eVar67'   : sProp67,
	  'prop67'    : sProp67,
	  'prop68'    : sProp68,
	  'list2'	 : taxonomies,
	  'WT omnituretracking.tag' : 'story'
	});
</script>

<noscript>
	<img src="http://newyorktimes.112.2o7.net/b/ss/nytbostonglobecom/1/H.23.3--NS/0?pageName=News%20%7C%20BGC%20Homepage&amp;ch=News&amp;c1=News%20%7C%20BGC%20Homepage&amp;c6=BGC%20Homepage&amp;c41=BostonGlobe.com&amp;v41=BostonGlobe.com" height="1" width="1" border="0" alt="" />
</noscript>


</div>
<script src="/js/dist/globe-sticky-tools.js,dist/globe-sticky-masthead.js,dist/globe-topic-nav.js,dist/globe-analytics.js,dist/lib/modernizr.custom.min.js?v=18279I1728"></script>
<link rel="stylesheet" type="text/css" href="//meter.bostonglobe.com/css/style.css">
<script src="//meter.bostonglobe.com/js/meter.js"></script>
<script src="/js/dist/globe-header.js,dist/globe-blueconic.js,dist/chartbeat.js,dist/continue-reading.js,dist/globe-subscription-banner.js,dist/globe-adcatalog.js,dist/globe-adinclude.js,dist/globe-comments.js,dist/globe-masthead.js?v=18279I1728"></script>
<script type="text/javascript">
	(function() {
		if (typeof window.meterObject !== 'undefined') {
			
			// Change the meter base URL (this allows all campaign links to be relative) for this particular environment.
			window.meterObject.updateBaseURL('https://www.bostonglobe.com');
			
			window.meterObject.executeMeter({
				loid:'4.3.3688958225',
				uuid:'b7c7e592-76d5-11e7-af4f-c28365d4658d',
				
				exemptFromMeter: false
			});
			
		}

	})();
</script>
</body>
</html>

